All In MedTech

FDA Clearance Tracker · DEN240066

COAPTIUM Connect with TISSIUM LIGHT

A De Novo grant creates a new device type for a low to moderate risk device with nothing on the market to compare it to. Later devices of this type can use it as their comparison in a 510(k).

Last checked: Nov 20, 2026Latest source record: Jun 17, 2025 (this decision)Source: openFDAMethods & limitations

De NovoNew device type

Decided

Jun 17, 2025

De Novo granted

Time to decision

208 days

Received Nov 21, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

De Novo

Direct

Device class

Class II

The decision

FDA number
DEN240066
Device name
COAPTIUM Connect with TISSIUM LIGHT
Applicant
Tissium SA
Applicant location
Paris, FR
Received
Nov 21, 2024
Decided
Jun 17, 2025
Decision
De Novo granted
Submission type
Direct

Device type

Device class
Class II
Regulation
21 CFR 882.5270

Every decision under product code SFD

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Tissium SA

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.